Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Effect of Intra-Tympanic Methyl Prednisone-platelet Rich Plasma Combination in Sensorineural Hearing Loss and Tinnitus of Cochlear Origin.

NCT06025097 is registered in ClinicalTrials.gov with Combined Military Hospital Rawalpindi as lead sponsor.

NCT NCT06025097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06025097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Effect of Intra-Tympanic Methyl Prednisone-platelet Rich Plasma Combination in Sensorineural Hearing Loss and Tinnitus of Cochlear Origin.
Lead sponsor
Combined Military Hospital Rawalpindi
Phase
Phase 1
Overall status
Completed
Start date
September 1, 2023
Completion date
October 21, 2023
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sensorineural hearing loss, tinnitus